Related Experiment Video
Updated: Aug 17, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Drug-Resistant (DR) Tubercular Pleural Effusion: A Rare Case
Juhi Kadukar1, Gaurang M Aurangabadkar2, Pankaj Wagh1
1Respiratory Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.
Diagnosing drug-resistant tuberculosis pleural effusion is challenging. This case highlights successful management of multidrug-resistant tubercular pleural effusion using advanced diagnostics and a bedaquiline-containing regimen.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Tuberculosis (TB) remains a global health challenge, particularly in developing nations.
- Drug-resistant (DR) TB cases are increasing, complicating treatment strategies.
- Diagnosing tubercular pleural effusion is difficult due to low bacillary load and unreliable Ziehl-Neelsen staining.
Observation:
- A patient presented with symptoms suggestive of extra-pulmonary TB, initially misdiagnosed as drug-sensitive.
- Conventional anti-tubercular therapy for two months yielded no improvement.
- Pleural fluid analysis revealed exudative effusion with elevated adenosine deaminase (ADA) levels.
Findings:
- Advanced molecular diagnostics, including Xpert® MTB/R assay and Line Probe Assay (LPA), identified R- and H-resistant tubercular effusion.
- Drug sensitivity testing (DST) confirmed multidrug-resistant (MDR) tuberculosis.
- The patient showed significant improvement after initiating an oral bedaquiline-containing regimen.
Implications:
- This case underscores the importance of advanced diagnostics for accurate TB diagnosis, especially in drug-resistant cases.
- Bedaquiline-containing regimens offer a promising treatment option for multidrug-resistant tubercular pleural effusion.
- Improved diagnostic and treatment strategies are crucial for combating the rise of drug-resistant TB globally.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

